102 related articles for article (PubMed ID: 7682169)
1. Co-oxydextran as a protectant against gentamicin-induced renal lysosomal phospholipidosis and focal tubular necrosis. Perspectives and limitations.
Kishore BK; Van Schepdael A; Laurent G; Lambricht P; Claes PJ; Piret J; Tulkens PM; Maldague P
Contrib Nephrol; 1993; 101():213-9. PubMed ID: 7682169
[No Abstract] [Full Text] [Related]
2. Leupeptin and E-64, inhibitors of cysteine proteinases, prevent gentamicin-induced lysosomal phospholipidosis in cultured rat fibroblasts.
Montenez JP; Kishore BK; Maldague P; Tulkens PM
Toxicol Lett; 1994 Sep; 73(3):201-8. PubMed ID: 8091428
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
[TBL] [Abstract][Full Text] [Related]
4. Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study.
Nonclercq D; Wrona S; Toubeau G; Zanen J; Heuson-Stiennon JA; Schaudies RP; Laurent G
Ren Fail; 1992; 14(4):507-21. PubMed ID: 1462002
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of poly-L-aspartic and poly-L-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats.
Kishore BK; Ibrahim S; Lambricht P; Laurent G; Maldague P; Tulkens PM
J Pharmacol Exp Ther; 1992 Jul; 262(1):424-32. PubMed ID: 1378098
[TBL] [Abstract][Full Text] [Related]
7. Reduction of gentamicin nephrotoxicity by the concomitant administration of poly-l-aspartic acid and poly-l-asparagine in rats.
Beauchamp D; Laurent G; Maldague P; Tulkens PM
Arch Toxicol Suppl; 1986; 9():306-9. PubMed ID: 3468909
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of gentamicin-induced nephrotoxicity by lithium in rat.
Samadian T; Dehpour AR; Amini S; Nouhnejad P
Histol Histopathol; 1993 Jan; 8(1):139-47. PubMed ID: 8443425
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
[TBL] [Abstract][Full Text] [Related]
10. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
[TBL] [Abstract][Full Text] [Related]
11. Distribution of epidermal growth factor in the kidneys of rats exposed to amikacin.
Toubeau G; Nonclercq D; Zanen J; Lambricht P; Tulkens PM; Heuson-Stiennon JA; Laurent G
Kidney Int; 1991 Oct; 40(4):691-9. PubMed ID: 1745019
[TBL] [Abstract][Full Text] [Related]
12. Gentamicin induces a lysosomal phospholipidosis in cultured rat fibroblast [proceedings].
Goffeau A; Aubert-Tulkens G; Van Hoff F
Arch Int Physiol Biochim; 1978 May; 86(2):403-5. PubMed ID: 80995
[No Abstract] [Full Text] [Related]
13. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats.
Erdem A; Gündoğan NU; Usubütün A; Kilinç K; Erdem SR; Kara A; Bozkurt A
Nephrol Dial Transplant; 2000 Aug; 15(8):1175-82. PubMed ID: 10910441
[TBL] [Abstract][Full Text] [Related]
14. Long-term protection of polyaspartic acid in experimental gentamicin nephrotoxicity.
Swan SK; Kohlhepp SJ; Kohnen PW; Gilbert DN; Bennett WM
Antimicrob Agents Chemother; 1991 Dec; 35(12):2591-5. PubMed ID: 1810193
[TBL] [Abstract][Full Text] [Related]
15. L-carnitine ameliorates gentamicin-induced renal injury in rats.
Kopple JD; Ding H; Letoha A; Ivanyi B; Qing DP; Dux L; Wang HY; Sonkodi S
Nephrol Dial Transplant; 2002 Dec; 17(12):2122-31. PubMed ID: 12454222
[TBL] [Abstract][Full Text] [Related]
16. Renal tissue injury and proliferative response after successive treatments with anticancer platinum derivatives and tobramycin.
Nonclercq D; Toubeau G; Tulkens P; Heuson-Stiennon JA; Laurent G
Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(3):143-58. PubMed ID: 1980761
[TBL] [Abstract][Full Text] [Related]
17. Inability of nitrendipine to protect against gentamicin nephrotoxicity in the rat.
Kacew S
Biomed Environ Sci; 1989 Jun; 2(2):160-6. PubMed ID: 2556158
[TBL] [Abstract][Full Text] [Related]
18. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine.
Kacew S
Toxicol Appl Pharmacol; 1987 Dec; 91(3):469-76. PubMed ID: 3424375
[TBL] [Abstract][Full Text] [Related]
19. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats.
Giuliano RA; Paulus GJ; Verpooten GA; Pattyn VM; Pollet DE; Nouwen EJ; Laurent G; Carlier MB; Maldague P; Tulkens PM
Kidney Int; 1984 Dec; 26(6):838-47. PubMed ID: 6533395
[TBL] [Abstract][Full Text] [Related]
20. Effect of rosmarinic acid on inhibition of gentamicin induced nephrotoxicity in rats.
Tavafi M; Ahmadvand H
Tissue Cell; 2011 Dec; 43(6):392-7. PubMed ID: 22000907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
